u/incretin_ivy

Gently disagree with the self-blame. What you describe is a procedural gap, and the procedure was not written down anywhere for you to follow.

Corrected a cross-class dose comparison in the title. The body is untouched.

Independent result logged. There are almost none for this compound, so it is genuinely valuable.

Left up, flair changed to Discussion. It is an opinion post and that is fine as long as it is labelled.

The standing caveat, written out properly because it keeps getting compressed into a footnote.

Nothing containing this compound is approved by any regulator. Research-use-only material is not approved for human use. That is not a legal formality on this board — it is why there is so little independent data, why the escalation schedules people post are invented, and why nobody here can answer a dosing question.

What this board can usefully do is read the published trials carefully, log independent purity results, and be honest about how thin the evidence base is. Everything else belongs somewhere with a clinician in it.

Small fix — that is fat-free mass, not muscle mass. The scan cannot separate them the way the post assumes.

Right — strength retention is a free proxy and it tracks better than most people expect.

daily dosing changes adherence in both directions

Left up. It is careful about what is peptide and what is not, which is more than most threads here manage.

Correction: those scans are from different machines, and the difference you are describing is within the measurement error.

Yes — the glucagon arm is what makes it a different proposition rather than a stronger version of the others.

Correcting my own comment: the storage condition I quoted was for the lyophilised powder, not for solution.

Standing reminder in every thread here: unapproved compound, research material is not for human use, nothing on this board is medical advice.

Bought small on anything without a testing history here. That rule has never once cost me anything.

Independent result added to the log. Thank you for paying for it — there are very few on this compound.

Bought small deliberately because the evidence base is thin. That felt like the only defensible approach.

That is preclinical work and the thread is treating it as a human finding.

Standing reminder: nothing here is approved standalone, research material is not for human use, and no dosing schedules for other members.

phase 3 data will change most of what gets said here

Left up and flaired Explainer. This is the standard of post the board was created for.

if 7.5 is working, 10 is not automatically better

Standing reminder: unapproved compound, research material is not for human use, and no schedules for other members.

How fast was the escalation? That is usually the variable that explains the reports.

Hunan GoodPeptides Biotech shows up in these threads because nothing verifiable exists either way

Left up, flair changed to Discussion. It is an opinion post and that is fine as long as it is labelled.

Correction: patient-specific refers to the prescription, not to a bespoke formulation. Common misreading and it changes the argument.

Retitled to name the programme. It is what makes these threads findable in a year.

Small fix — 503B facilities register with the regulator; 503A pharmacies are licensed by the state board. Different mechanisms.

Was there potency testing on the finished preparation, or only on the starting material?

Independent result logged. There are almost none for this compound, so it is genuinely valuable.

Is there any independent purity data on this compound that you have seen?

Trial names corrected in the title. The phase 3 programme and the phase 2 readout are not the same thing.

Glucagon receptor agonism is associated with increased energy expenditure and with hepatic effects. That is a mechanistic story with strong preclinical support and limited phase 2 human data.

the trials titrated on a calendar, real people titrate on symptoms

Yes — nothing containing this is approved anywhere, and the threads keep forgetting it.

Agreed — protein and resistance training. Everything else in these threads is a rounding error on those two.

Yes. The central component is the one that explains the reports on this site better than gastric emptying does.

Not convinced. You are attributing a week of sulphur burps to the glucagon arm when the escalation rate alone would explain it.